Amazon

Friday, November 25, 2016

DEA Schedules Deadly Synthetic Drug U-47700

Responding
to the imminent threat to public health and safety, the U.S. Drug Enforcement
Administration (DEA) has placed U-47700 into Schedule I of the Controlled
Substances Act, effective on November 14. Emergency scheduling of dangerous
drugs such as U-47700 on a temporary basis is one of the most significant tools
DEA can utilize to address the problems associated with deadly new street
drugs. U-47700 is a novel synthetic opioid, and its abuse parallels that of
heroin, prescription opioids and other novel opioids. Law enforcement agencies
report seizures of the drug in powder form and counterfeit tablets that mimic
pharmaceutical opioids. Abuse of the drug often happens unknowingly to the
user, and it is encountered as a single substance as well as in combination
with other drugs such as heroin and fentanyl. DEA received reports of at least
46 confirmed fatalities associated with U-47700, 31 of which occurred in New
York and 10 in North Carolina. From October 2015 to September 2016, DEA
received 88 reports from state and local forensic laboratories of U-47700
submissions. For information, see https://www.dea.gov/divisions/hq/2016/hq111016.shtml.